
|Articles|January 24, 2005
Sleep aid is first agent not limited to short-term use
Insomnia is one of the most common sleep disturbances in the United States, affecting an estimated 100 million Americans. According to the 2002 Sleep in America poll from the National Sleep Foundation, 58% of adults experience symptoms of insomnia a few nights or more per week at some point in their lives. The total economic costs associated with insomnia have been estimated at $17.5 billion.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Severe COVID-19 Increases Stroke Risk for Patients With Asthma
2
The Variety of Migraine Treatment Options Opens the Door for Pharmacy Services | NCPA 2025
3
The Rise in Supplement Use Calls for Pharmacist-Led Counseling, Education | NCPA 2025
4
How Community Pharmacists Are Proactively Managing Patients’ Migraines | NCPA 2025
5